Danish method study on cervical screening in women offered HPV vaccination as girls (Trial23): a study protocol.

ABSTRACT:

Introduction

The first birth cohorts of women offered human papillomavirus (HPV) vaccination as girls are now entering cervical screening. However, there is no international consensus on how to screen HPV vaccinated women. These women are better protected against cervical cancer and could therefore be offered less intensive screening. Primary HPV testing is more sensitive than cytology, allowing for a longer screening interval. The aim of Trial23 is to investigate if primary HPV testing with cytology triage of HPV positive samples is a reasonable screening scheme for women offered HPV vaccination as girls.

Methods

Trial23 is a method study embedded in the existing cervical screening programme in four out of five Danish regions. Without affecting the screening programme, wome

SUBMITTER: Thamsborg LH 

PROVIDER: S-EPMC5988093 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature